|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows used in operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Accrued expenditures for government grant | ||
| Accrued interest | ||
| Loss on derivative liabilities and conversion of convertible debt | ||
| Accrued interest income, related party | ||
| Loss (gain) on derivative liabilities and conversion of convertible debt | ||
| Change in fair value of bonus rights liability | ||
| Non-cash debt issuance costs | ||
| Provision for loan losses | ||
| Impairment of intangible assets | ||
| Loss on disposal of equipment | ||
| Stock-based compensation | ||
| Shares issued for services | ||
| Changes in non-cash operating working capital items: | ||
| Accounts receivable, net | ||
| Inventories | ||
| Prepaid expenses and other current assets | ||
| Accounts payable and accrued liabilities | ||
| Deferred income | ||
| Net cash used in operating activities | ||
| Cash flows used in investing activities | ||
| Acquisition of equipment | ||
| Net cash used in investing activities | ||
| Cash flows provided by financing activities | ||
| Units issued for cash | ||
| Stock issued for cash | ||
| Stock issuance costs | ||
| Warrants issued for cash | ||
| Funds repaid on promissory notes | ||
| Exercise of options | ||
| Exercise of warrants | ||
| Proceeds received from restricted government grant | ||
| Amounts paid from restricted government grant funds | ||
| Proceeds from the issuance of convertible debentures | ||
| Debt issuance costs | ||
| Net cash provided by financing activities | ||
| Change in cash and cash equivalents during the year | ||
| Change in cash, cash equivalents, and restricted cash during the year | ||
| Cash, cash equivalents, and restricted cash beginning of year | ||
| Cash, cash equivalents, and restricted cash end of year | ||
| Demand deposits | ||
| Restricted cash | ||
| Total cash and cash equivalents | ||
| Supplemental Disclosure | ||
| Cash paid for interest | ||
| Supplemental non-cash disclosures | ||
| Reallocation of fair value of share options upon exercise | ||
| Reclassification of derivative liability of warrants exercised | ||
| Reclassification of derivative liability for warrants re-priced from CAD to USD exercise price | ||
| Recognition of Option liabilities | ||
| Common shares issued for share issuance costs | ||
| Warrants issued for share issuance costs | ||
| Common shares issued for services |
Loading...
